Added to YB: 2021-05-01
Pitch date: 2021-05-01
CVAC [bearish]
CureVac N.V.
+95.82%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
Market Cap
$1.0B
Pitch Price
$120.71
Price Target
N/A
Dividend
N/A
EV/EBITDA
2.68
P/E
5.38
EV/Sales
1.33
Sector
Biotechnology
Category
N/A
Show full summary:
CUREVAC NV CVAC
A summary for this pitch has not been created yet.
Read full article (0 min)